LMR Partners LLP Acquires 10,330 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

LMR Partners LLP boosted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 23.3% during the third quarter, HoldingsChannel reports. The fund owned 54,744 shares of the medical device company’s stock after purchasing an additional 10,330 shares during the quarter. LMR Partners LLP’s holdings in Cooper Companies were worth $6,040,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Innealta Capital LLC acquired a new position in shares of Cooper Companies in the 2nd quarter worth approximately $25,000. Ashton Thomas Securities LLC bought a new stake in Cooper Companies during the 3rd quarter valued at $25,000. Covestor Ltd increased its stake in Cooper Companies by 305.9% during the 1st quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after purchasing an additional 208 shares in the last quarter. Crewe Advisors LLC grew its stake in shares of Cooper Companies by 286.4% in the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock worth $30,000 after acquiring an additional 252 shares in the last quarter. Finally, Tortoise Investment Management LLC grew its stake in shares of Cooper Companies by 75.4% in the 2nd quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock worth $34,000 after acquiring an additional 169 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Trading Down 0.2 %

Cooper Companies stock opened at $99.48 on Tuesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The stock has a market cap of $19.81 billion, a PE ratio of 55.42, a price-to-earnings-growth ratio of 2.15 and a beta of 0.99. The stock has a 50-day moving average of $106.66 and a two-hundred day moving average of $98.12. The Cooper Companies, Inc. has a one year low of $82.21 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the company earned $0.84 earnings per share. On average, research analysts anticipate that The Cooper Companies, Inc. will post 3.65 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the topic of several recent research reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Stifel Nicolaus reiterated a “buy” rating and set a $115.00 price target (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Morgan Stanley raised their price objective on Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 10th. StockNews.com raised Cooper Companies from a “hold” rating to a “buy” rating in a research report on Thursday, November 14th. Finally, Wells Fargo & Company lifted their price target on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Insiders Place Their Bets

In related news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the transaction, the chief executive officer now directly owns 165,273 shares in the company, valued at approximately $18,267,624.69. This trade represents a 41.03 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the transaction, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. This represents a 24.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 256,373 shares of company stock valued at $27,637,427. 2.00% of the stock is currently owned by corporate insiders.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.